Store

Home
Hikma Injectables USA Inc
Dayton Jun 2022 483

483 Document: Hikma Injectables USA Inc, Jun 8, 2022

Jay B. Shah, FDA Investigator
Edmund F. Mrak, FDA Investigator
Samir C. Gala, FDA Investigator

FDANews 483 Hikma Injectables USA Inc Jun 8 2022 top

Jay B. Shah FDA Investigator Edmund F. Mrak FDA Investigator Samir C. Gala FDA Investigator

On Jun 08, 2022, the FDA inspected Hikma Injectables USA Inc's Dayton site. Explore the inspectional observations.

Hikma Injectables USA Inc

483 Document

Issued: Jun 8, 2022

Details

Human DrugInspection
Dayton / United States
17 days

Available for Download - $199

[email protected]
+1 (650) 646-4996

About

About Us
Terms of Service
Privacy Policy
Support

GMP Resources

FDA Inspections DB

FDA Form 483 Database

Document Review

Related Apps

Quality Regulatory Intelligence

Redica Platform

Formerly FDAzilla, Redica is a data analytics platform built for the life sciences to improve product quality and reduce regulatory risk.

Clinical Trials Analytics

Clincosm

Marketplace connecting patients to clinical trials to accelerate patient recruitment is accelerating medicine

Productivity

CalendarCrush

App for calendar-driven people to account and bill for their time

Spectator Sports

BlitzSports

Score Clock App for youth sports parents asked to be time-keeper. This is the scorekeeping of the future.

Copyright © 2007 - 2024 Zymergi, Inc.